Cargando…
Method of establishing breast cancer brain metastases affects brain uptake and efficacy of targeted, therapeutic nanoparticles
HER2‐targeted therapies effectively control systemic disease, but their efficacy against brain metastases is hindered by their low penetration of the blood‐brain and blood‐tumor barriers (BBB and BTB). We investigate brain uptake and antitumor efficacy of transferrin receptor (TfR)‐targeted, therape...
Autores principales: | Wyatt, Emily A., Davis, Mark E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336738/ https://www.ncbi.nlm.nih.gov/pubmed/30680316 http://dx.doi.org/10.1002/btm2.10108 |
Ejemplares similares
-
In Vivo Methods to Study Uptake of Nanoparticles into the Brain
por: van Rooy, Inge, et al.
Publicado: (2010) -
Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020) -
Profiles of brain metastases: Prioritization of therapeutic targets
por: Ferguson, Sherise D., et al.
Publicado: (2018) -
Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
por: Terceiro, Lucas E. L., et al.
Publicado: (2023) -
Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics
por: Bollig-Fischer, Aliccia, et al.
Publicado: (2015)